ImmunoHorizons

ImmunoHorizons has been selected for inclusion in MEDLINE!
Submit a manuscript now!

Latest Articles

Open Access
Analysis of MHC Class I Processing Pathways That Generate a Response to Vaccinia Virus Late Proteins
Ting Kuang Niu, Michael F. Princiotta, Janet J. Sei and Christopher C. Norbury

ImmunoHorizons December 1, 2019, 3 (12) 559-572; DOI: https://doi.org/10.4049/immunohorizons.1900074
Open Access
Dissociating STAT4 and STAT5 Signaling Inhibitory Functions of SOCS3: Effects on CD8 T Cell Responses
Ji Young Hwang, John E. Holland, Kristine B. Valenteros, Yanbo Sun, Young-Kwang Usherwood, Andreia F. Verissimo, Jason S. McLellan, Gevorg Grigoryan and Edward J. Usherwood

ImmunoHorizons November 1, 2019, 3 (11) 547-558; DOI: https://doi.org/10.4049/immunohorizons.1800075
Open Access
Galectin-9 Expression Defines a Subpopulation of NK Cells with Impaired Cytotoxic Effector Molecules but Enhanced IFN-γ Production, Dichotomous to TIGIT, in HIV-1 Infection
Melika Motamedi, Shima Shahbaz, Li Fu, Garett Dunsmore, Lai Xu, Robert Harrington, Stan Houston and Shokrollah Elahi

ImmunoHorizons November 1, 2019, 3 (11) 531-546; DOI: https://doi.org/10.4049/immunohorizons.1900087
Open Access
Effect of a C1s Inhibitor on the Efficacy of Anti-Capsular Antibodies against Neisseria meningitidis and Streptococcus pneumoniae
Lisa A. Lewis, Sandip Panicker, Rosane B. DeOliveira, Graham C. Parry and Sanjay Ram

ImmunoHorizons November 1, 2019, 3 (11) 519-530; DOI: https://doi.org/10.4049/immunohorizons.1900031
Open Access
Oxidative Stress Enhances Dendritic Cell Responses to Plasmodium falciparum
Anton Götz, Maureen C. Ty and Ana Rodriguez

ImmunoHorizons November 1, 2019, 3 (11) 511-518; DOI: https://doi.org/10.4049/immunohorizons.1900076
Open Access
Homotaurine Treatment Enhances CD4⁺ and CD8⁺ Regulatory T Cell Responses and Synergizes with Low-Dose Anti-CD3 to Enhance Diabetes Remission in Type 1 Diabetic Mice
Jide Tian, Hoa Dang, Karen Anne O’Laco, Min Song, Bryan-Clement Tiu, Spencer Gilles, Christina Zakarian and Daniel L. Kaufman

ImmunoHorizons October 1, 2019, 3 (10) 498-510; DOI: https://doi.org/10.4049/immunohorizons.1900019

About ImmunoHorizons

ImmunoHorizons is an open access, fully peer-reviewed journal committed to advancing the knowledge of immunology. Published articles will cover all areas of basic and clinical immunology. All editorial decisions are made by practicing scientists. ImmunoHorizons is published by The American Association of Immunologists (AAI).